Stockscreener 앱 받기
8.54
5.43%
-0.49
전일 마감가:
$9.03
열려 있는:
$8.8
하루 거래량:
20,103
Relative Volume:
0.05
시가총액:
$4.72M
수익:
$927.00K
순이익/손실:
$-13.21M
주가수익비율:
-0.0405
EPS:
-210.8843
순현금흐름:
$-4.77M
1주 성능:
+29.79%
1개월 성능:
+137.38%
6개월 성능:
-70.80%
1년 성능:
+246.69%
1일 변동 폭
$8.00
$8.80
1주일 범위
$6.01
$9.03
52주 변동 폭
$2.448
$80.10
Scisparc Ltd Stock (SPRC) Company Profile
Compare SPRC vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
8.35 | 4.72M | 927.00K | -13.21M | -4.77M | -210.88 |
VRTX
Vertex Pharmaceuticals Inc
|
429.05 | 109.41B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
705.85 | 76.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
786.17 | 48.20B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.31B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
296.37 | 33.13B | 5.36B | 287.73M | 924.18M | 2.5229 |
Scisparc Ltd 주식(SPRC)의 최신 뉴스
Neurothera Labs Announces Continuance into Ontario - TheNewswire
SciSparc (NASDAQ: SPRC) 20-F shows widening losses and going concern risk - Stock Titan
SPRC Stock Price, Quote & Chart | SCISPARC LTD (NASDAQ:SPRC) - ChartMill
SciSparc stock rallies after AutoMax files motion on pending merger - MSN
SPRC Technical Analysis | Trend, Signals & Chart Patterns | SCISPARC LTD (NASDAQ:SPRC) - ChartMill
Neurothera Labs Engages bullVestor for Investor Relations Activities - TheNewswire
SciSparc receives Nasdaq notice over stockholders’ equity shortfall - MSN
SPRC Stock Pops On Volatile Run As Traders Circle - timothysykes.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
SciSparc (SPRC) Stock Volume Ratio (Slips) 2026-04-20RSI Overbought Stocks - Cổng thông tin điện tử tỉnh Lào Cai
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Amnon Ben Shay Net Worth (2026) - GuruFocus
Adi Zuloff Shani Net Worth (2026) - GuruFocus
Lior Vider Net Worth (2026) - GuruFocus
Is SciSparc (SPRC) Stock better than industry peers | Price at $3.02, Down 3.95%Open Stock Signal Network - UBND thành phố Hải Phòng
Block Trades: Can SciSparc Ltd scale operations efficientlyQuarterly Portfolio Summary & Breakout Confirmation Alerts - baoquankhu1.vn
Institution Moves: Can SciSparc Ltd outperform in the next rallyEntry Point & Community Verified Swing Trade Signals - baoquankhu1.vn
Market Trends: What makes SciSparc Ltd stock attractive todayOptions Play & Safe Entry Point Alerts - baoquankhu1.vn
MACD Signal: Is SciSparc Ltd impacted by rising ratesWeekly Risk Summary & Real-Time Buy Zone Alerts - baoquankhu1.vn
Institution Moves: Is SciSparc Ltd impacted by rising rates2026 Drop Watch & Breakout Confirmation Alerts - baoquankhu1.vn
Buyback Watch: Can SciSparc Ltd outperform in the next rallyWeekly Trade Analysis & Smart Allocation Stock Tips - baoquankhu1.vn
SPRC Should I Buy - Intellectia AI
Is SciSparc (SPRC) Stock sensitive to interest rates | Price at $3.54, Down 3.28%Crowd Entry Signals - Xã Châu Thành
SPRC Stock Analysis: SciSparc Ltd. Ordinary Shares biotech 0.41% dip at 3.66 view - UBND thành phố Hải Phòng
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Whale Trades: How correlated is SciSparc Ltd to the S P5002026 Macro Impact & Entry Point Confirmation Alerts - baoquankhu1.vn
SciSparc (SPRC) director Dayan Alon reports 3,651-share ownership stake - Stock Titan
SPRC SEC FilingsScisparc 10-K, 10-Q, 8-K Forms - Stock Titan
SciSparc (SPRC) director discloses shares, options and RSU awards - stocktitan.net
SciSparc (SPRC) director reports initial share and option holdings - Stock Titan
SciSparc (SPRC) director Revach Moshe discloses initial share and RSU holdings - Stock Titan
SciSparc (SPRC) CEO Adler Oz details share, option and RSU holdings - Stock Titan
SciSparc (SPRC) director Weiss Amitay details equity holdings - Stock Titan
SciSparc (SPRC) director Vider Lior details shares, options and RSUs - Stock Titan
SciSparc (SPRC) CTO details 5,528 Ordinary Shares and option holdings on Form 3 - Stock Titan
SciSparc (SPRC) director reports 3,651-share stake and RSU grants - Stock Titan
Sentiment Watch: Can SciSparc Ltd stock outperform in a bear marketRecession Risk & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Buyout Rumor: Is SciSparc Ltd impacted by rising ratesMarket Performance Report & Low Drawdown Investment Ideas - baoquankhu1.vn
SciSparc subsidiary files patent for depression treatment By Investing.com - Investing.com India
[SCHEDULE 13G] SciSparc Ltd. Passive Investment Disclosure (>5%) - Stock Titan
SciSparc’s NeuroThera-Backed Collaboration Spurs New Depression Therapy Patent Filing - TipRanks
Eli Zamir reports ≤5% stake in SciSparc (NASDAQ: SPRC) - Stock Titan
SciSparc (NASDAQ: SPRC) collaboration advances MEAI-PEA depression patent bid - Stock Titan
SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy - Bitget
SciSparc subsidiary files patent for depression treatment - Investing.com
SciSparc Ltd. Reports NeuroThera Labs' Patent Application for Innovative Depression Treatment Combining MEAI and PEA - quiverquant.com
SciSparc Subsidiary NeuroThera to Take Majority Stake in Quantum Trials Firm CliniQuantum - TipRanks
SciSparc (Nasdaq: SPRC) unit to acquire 54% of CliniQuantum and lose NeuroThera control - Stock Titan
SciSparc’s Neurothera Labs announces publication of international patent - TipRanks
SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease - Bitget
SciSparc Ltd. Advances Collaboration with NeuroThera Labs Inc. and Clearmind Medicine Inc. for Novel Combination Therapy Targeting Obesity and MASLD. - Quiver Quantitative
Scisparc Ltd (SPRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.96%
자본화:
|
볼륨(24시간):